my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
27-11-2009: iThemba Pharmaceuticals’ service division and Pyxis Discovery announced that they have signed a collaborative agreement to jointly market both companies’ services.
Pyxis’s computational chemistry and lead discovery expertise will be coupled with iThemba’s service division to provide medicinal and synthetic chemistry support to projects identified through Pyxis’ international client network. iThemba Pharmaceuticals and Pyxis Discovery also announced that they are entering into a co-marketing agreement to offer virtual libraries which will be exclusively synthesized for clients. Pyxis’s smart approach of designing and selecting compounds facilitates a rapid and efficient lead discovery and library design process and this coupled to iThemba’s expertise in synthetic and medicinal chemistry will provide our customers with a unique service offering opportunity.
“The intellectual and technological support from Pyxis will enhance both of our service offerings” said Chris Edlin, CSO of iThemba. “Our customers will gain the advantage of our coupled expertise in design, synthesis and medicinal chemistry prowess”.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
iThemba Pharmaceuticals’ service division and Pyxis Discovery announced that they have signed a collaborative agreement to jointly market both companies’ services. Pyxis’s computational chemistry and lead discovery expertise will be coupled with iThemba’s service division to provide medic ... more
Pharming receives funding for development of new treatments for premature ageing diseases
Pharming Group NV announced that its wholly owned subsidiary DNage will head a collaborative Research and Development effort to identify novel biomarkers and therapeutic targets, and to develop therapeutics for the treatment of premature ageing diseases. The consortium has been granted a Se ... more
Galapagos NV, ZoBio BV, Pyxis Discovery BV and Leiden University announced the formation of a four-way collaboration to pursue a small molecule drug discovery program in the area of arthritis. The collaboration, funded in part by an IS ("Innovatiesubsidie Samenwerkingsprojecten") grant from ... more
iThemba Pharmaceuticals’ service division and Pyxis Discovery announced that they have signed a collaborative agreement to jointly market both companies’ services. Pyxis’s computational chemistry and lead discovery expertise will be coupled with iThemba’s service division to provide medic ... more
iThemba Pharmaceuticals (Pty) Ltd
iThemba Pharmaceuticals (Pty) Ltd., based in Modderfontein, Gauteng, South Africa is founded to discover and develop new and affordable medicines for the diseases of poverty in Africa. The company is funded by the Biotechnology Regional Innovation Centers, LIFElab and BioPAD of the Departme ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
